mp-MRI prostate characterised PIRADS 3 lesions are associated with a low risk of clinically significant prostate cancer - a retrospective review of 92 biopsied PIRADS 3 Lesions

被引:0
|
作者
Liddell, H. [1 ]
Jyoti, R. [2 ]
Haxhimolla, H. Z. [1 ,3 ]
机构
[1] Canberra Hosp, Dept Urol, Garran, Australia
[2] Calvary Hosp, Universal Med Imaging, Bruce, Australia
[3] Australian Natl Univ, Acton, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
201
引用
收藏
页码:95 / 96
页数:2
相关论文
共 50 条
  • [21] Evaluating the risk of clinically significant prostate cancer in lesions detected on multiparametric MRI of the prostate.
    Molokwu, Chidi N.
    Gkikas, Christos
    Lee, Nicola
    Lesniak-Buzon, Joanna
    Ali, Faisal
    Bardgett, Harry
    CANCER PREVENTION RESEARCH, 2023, 16 (01)
  • [22] Prevalence of clinically significant prostate carcinoma in Prostate Imaging Reporting and Data System (PIRADS) 3 lesions detected in the peripheral zone on biparametric magnetic resonance imaging (MRI)da local experience
    Khalid, M. J.
    Parker, P.
    Smith, S.
    Byass, O. R.
    Cast, J. E. I.
    CLINICAL RADIOLOGY, 2024, 79 (10) : 773 - 780
  • [23] PIRADS ≥ 4 MRI lesion: Is performing systematic biopsies still essential for detecting clinically significant prostate cancer?
    Taha, Fayek
    Branchu, Benjamin
    Demichel, Natacha
    Goudaimy, Sulaiman
    Bui, Alexandre Patrick
    Delchet, Ophelie
    Larre, Stephane
    FRENCH JOURNAL OF UROLOGY, 2024, 34 (02):
  • [24] USEFULNESS OF FREE PSA RATIO TO ENHANCE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN PATIENTS WITH PIRADS <3 AND PSA ≤10
    Kang, Kevin
    Park, Chang Rae
    Heo, Ji Eun
    Lee, Kwang Suk
    Jang, Won Sik
    Ham, Won Sik
    Han, Woong Kyu
    Kim, Jang Hwan
    Choi, Young Deuk
    Lee, Jongsoo
    Kang, Kevin
    JOURNAL OF UROLOGY, 2024, 211 (05): : E785 - E786
  • [25] PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer
    Frisbie, James W.
    Van Besien, Alexa J.
    Lee, Adrianna
    Xu, Linhan
    Wang, Shu
    Choksi, Ankur
    Afzal, M. Adil
    Naslund, Michael J.
    Lane, Barton
    Wong, Jade
    Wnorowski, Amelia
    Siddiqui, Mohummad Minhaj
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (02) : 347 - 352
  • [26] PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer
    James W. Frisbie
    Alexa J. Van Besien
    Adrianna Lee
    Linhan Xu
    Shu Wang
    Ankur Choksi
    M. Adil Afzal
    Michael J. Naslund
    Barton Lane
    Jade Wong
    Amelia Wnorowski
    Mohummad Minhaj Siddiqui
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 347 - 352
  • [28] WHERE IS MP-MRI MORE ACCURATE IN DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER? AN ANALYSIS BASED ON ANATOMICAL PROSTATE AREAS
    Oglio, Paolo Dell'
    Stabile, Armando
    Boeri, Luca
    De Cobelli, Francesco
    Scuderi, Simone
    Brembilla, Giorgio
    Fossati, Nicola
    Gandaglia, Giorgio
    Zaffuto, Emanuele
    Esposito, Antonio
    Soligo, Matteo
    Capitanio, Umberto
    Barletta, Francesco
    Karnes, R. Jeffrey
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2019, 201 (04): : E518 - E518
  • [29] PREDICTIVE VALUE OF PIRADS V2 FOR ANY AND CLINICALLY SIGNIFICANT PROSTATE CANCER ON PROSTATE BIOPSY IN A HIGH RISK ETHNIC COHORT
    Lin, Wilson
    Fram, Ethan
    Chernyak, Victoria
    Watts, Kara
    JOURNAL OF UROLOGY, 2018, 199 (04): : E183 - E184
  • [30] A Novel Nomogram Combined the Aggregate Index of Systemic Inflammation and PIRADS Score to Predict the Risk of Clinically Significant Prostate Cancer
    Xie, Wenliang
    Xu, Zifan
    Qiu, Yifan
    Ye, Wei
    Zhang, Zhiyu
    Wang, Chao
    Zang, Jin
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023